• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白寡聚物与帕金森病路易体相关病理分布的差异。

Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson's disease.

机构信息

Department of Neuroscience, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA.

Division of Neurology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.

出版信息

Acta Neuropathol Commun. 2022 Sep 6;10(1):133. doi: 10.1186/s40478-022-01440-6.

DOI:10.1186/s40478-022-01440-6
PMID:36068646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9450240/
Abstract

The pathological hallmarks of Parkinson's disease (PD) are α-synuclein (αSYN)-positive inclusions referred to as Lewy bodies and Lewy neurites, collectively referred to as Lewy-related pathology (LRP). LRP is thought to propagate in an ascending manner throughout the brain as the disease progresses. LRP is visible with histologic methods and is thought to represent a later stage of the disease process, while αSYN oligomers, which are not visible with routine histologic methods, are considered earlier. There is increasing evidence to suggest that αSYN oligomers may be more toxic than visible LRP. Detecting αSYN oligomers requires special techniques, and their distribution and association with clinical features are important research objectives. In this report, we describe the distribution of αSYN oligomers in multiple cortical and subcortical regions of PD using a proximity ligation assay (PLA). We observe widespread distribution of αSYN oligomers with PLA and more restricted distribution of LRP with αSYN immunohistochemistry. The distribution of αSYN oligomers differed from LRP in that αSYN oligomer burden was significantly greater in the neocortex, while LRP was greater in vulnerable subcortical regions, including the brainstem. We also found that cognitive impairment was associated with αSYN oligomers in the hippocampus. These results suggest that αSYN oligomers may be widely distributed in PD early in the disease process and that they may contribute to cognitive impairment in PD.

摘要

帕金森病(PD)的病理学特征是α-突触核蛋白(αSYN)阳性包涵体,称为路易体和路易神经突,统称为路易相关病理学(LRP)。随着疾病的进展,LRP 被认为以上升的方式在整个大脑中传播。LRP 可以通过组织学方法观察到,被认为代表疾病过程的后期阶段,而αSYN 寡聚体,不能通过常规组织学方法观察到,被认为是早期阶段。越来越多的证据表明,αSYN 寡聚体可能比可见的 LRP 更具毒性。检测αSYN 寡聚体需要特殊技术,其分布与临床特征的关联是重要的研究目标。在本报告中,我们使用邻近连接分析(PLA)描述了 PD 多个皮质和皮质下区域中αSYN 寡聚体的分布。我们观察到 PLA 检测到的αSYN 寡聚体分布广泛,而αSYN 免疫组织化学检测到的 LRP 分布受限。αSYN 寡聚体的分布与 LRP 不同,αSYN 寡聚体负荷在新皮质中显著增加,而 LRP 在易受影响的皮质下区域(包括脑干)中增加。我们还发现认知障碍与海马体中的αSYN 寡聚体有关。这些结果表明,αSYN 寡聚体可能在 PD 疾病过程的早期就广泛分布,并且可能导致 PD 中的认知障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62d/9450240/3886ade839d2/40478_2022_1440_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62d/9450240/941ac3740c96/40478_2022_1440_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62d/9450240/894c46325d68/40478_2022_1440_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62d/9450240/c27af8442abc/40478_2022_1440_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62d/9450240/dd4b117fb797/40478_2022_1440_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62d/9450240/ab2da52196ac/40478_2022_1440_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62d/9450240/590609cd66a3/40478_2022_1440_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62d/9450240/3886ade839d2/40478_2022_1440_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62d/9450240/941ac3740c96/40478_2022_1440_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62d/9450240/894c46325d68/40478_2022_1440_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62d/9450240/c27af8442abc/40478_2022_1440_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62d/9450240/dd4b117fb797/40478_2022_1440_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62d/9450240/ab2da52196ac/40478_2022_1440_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62d/9450240/590609cd66a3/40478_2022_1440_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d62d/9450240/3886ade839d2/40478_2022_1440_Fig7_HTML.jpg

相似文献

1
Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson's disease.α-突触核蛋白寡聚物与帕金森病路易体相关病理分布的差异。
Acta Neuropathol Commun. 2022 Sep 6;10(1):133. doi: 10.1186/s40478-022-01440-6.
2
Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain.α-突触核蛋白寡聚体的直接可视化揭示了帕金森病大脑中以前未被检测到的病理特征。
Brain. 2015 Jun;138(Pt 6):1642-57. doi: 10.1093/brain/awv040. Epub 2015 Mar 1.
3
A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body-like pathology.一种 Cullin-RING 泛素连接酶靶向外来的α-突触核蛋白并抑制路易小体样病理。
Sci Transl Med. 2019 Jun 5;11(495). doi: 10.1126/scitranslmed.aau6722.
4
14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.14-3-3 蛋白减少致病性 α-突触核蛋白的细胞间转移和传播。
J Neurosci. 2018 Sep 19;38(38):8211-8232. doi: 10.1523/JNEUROSCI.1134-18.2018. Epub 2018 Aug 9.
5
α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.α-突触核蛋白寡聚体诱导星形胶质细胞释放谷氨酸,并导致神经元过度的突触外 NMDA 受体活性,从而导致突触丢失。
J Neurosci. 2021 Mar 10;41(10):2264-2273. doi: 10.1523/JNEUROSCI.1871-20.2020. Epub 2021 Jan 22.
6
Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.丝氨酸129磷酸化α-突触核蛋白在转基因小鼠中的细胞核及神经突分布
Neuroscience. 2009 Jun 2;160(4):796-804. doi: 10.1016/j.neuroscience.2009.03.002. Epub 2009 Mar 9.
7
Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson's Disease.内皮细胞 LRP1-ICD 通过激活 PARP1 加速帕金森病小鼠模型中与认知相关的α-突触核蛋白病理和神经退行性变。
Mol Neurobiol. 2023 Feb;60(2):979-1003. doi: 10.1007/s12035-022-03119-4. Epub 2022 Nov 17.
8
Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson's disease.帕金森病患者脑和胃中可传播的α-突触核蛋白的种子活性。
Acta Neuropathol. 2021 Jun;141(6):861-879. doi: 10.1007/s00401-021-02312-4. Epub 2021 Apr 24.
9
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.半乳糖凝集素-3 塑造帕金森病中的毒性α-突触核蛋白菌株。
Acta Neuropathol. 2023 Jul;146(1):51-75. doi: 10.1007/s00401-023-02585-x. Epub 2023 May 18.
10
Exploring the accessible conformations of N-terminal acetylated α-synuclein.探索 N 端乙酰化 α-突触核蛋白的可及构象。
FEBS Lett. 2013 Apr 17;587(8):1128-38. doi: 10.1016/j.febslet.2013.02.049. Epub 2013 Mar 13.

引用本文的文献

1
Converging pathologies in neurodegeneration: the mechanistic interplay between α-Synuclein and Tau in Alzheimer's and Parkinson's.神经退行性变中的汇聚性病理:阿尔茨海默病和帕金森病中α-突触核蛋白与 Tau 蛋白之间的机制相互作用
Neurol Sci. 2025 Aug 26. doi: 10.1007/s10072-025-08421-2.
2
Impact of hippocampal α-synuclein oligomers on cognitive trajectory in patients with dementia with Lewy bodies.海马α-突触核蛋白寡聚体对路易体痴呆患者认知轨迹的影响。
Alzheimers Dement. 2025 Aug;21(8):e70374. doi: 10.1002/alz.70374.
3
Current strategies in the management of dementia with lewy bodies and future directions based on disease pathophysiology.

本文引用的文献

1
Pathological substrate of memory impairment in multiple system atrophy.多系统萎缩记忆障碍的病理基础。
Neuropathol Appl Neurobiol. 2022 Dec;48(7):e12844. doi: 10.1111/nan.12844. Epub 2022 Aug 12.
2
Old age amyotrophic lateral sclerosis and limbic TDP-43 pathology.老年肌萎缩侧索硬化症和边缘 TDP-43 病理学。
Brain Pathol. 2022 Nov;32(6):e13100. doi: 10.1111/bpa.13100. Epub 2022 Jun 17.
3
Clinical and pathological characteristics of later onset multiple system atrophy.迟发性多系统萎缩的临床和病理特征。
路易体痴呆的当前管理策略及基于疾病病理生理学的未来方向。
Mol Neurodegener. 2025 Jul 1;20(1):78. doi: 10.1186/s13024-025-00856-7.
4
Immunization targeting diseased proteins in synucleinopathy and tauopathy: insights from clinical trials.针对突触核蛋白病和tau蛋白病中患病蛋白的免疫疗法:来自临床试验的见解
Transl Neurodegener. 2025 Jul 1;14(1):33. doi: 10.1186/s40035-025-00490-9.
5
Widespread distribution of α-synuclein oligomers in LRRK2-related Parkinson's disease.α-突触核蛋白寡聚体在与富亮氨酸重复激酶2(LRRK2)相关的帕金森病中的广泛分布。
Acta Neuropathol. 2025 May 2;149(1):42. doi: 10.1007/s00401-025-02872-9.
6
Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases.路易体阴性的LRRK2突变病例中存在大量非包涵体型α-突触核蛋白病理改变。
Acta Neuropathol. 2025 May 2;149(1):41. doi: 10.1007/s00401-025-02871-w.
7
The α-Synuclein Seeding Amplification Assay for Parkinson's Disease.用于帕金森病的α-突触核蛋白种子扩增检测法
Int J Mol Sci. 2025 Jan 4;26(1):389. doi: 10.3390/ijms26010389.
8
Machine Learning for Early Detection of Cognitive Decline in Parkinson's Disease Using Multimodal Biomarker and Clinical Data.利用多模态生物标志物和临床数据的机器学习用于帕金森病认知衰退的早期检测
Biomedicines. 2024 Dec 3;12(12):2758. doi: 10.3390/biomedicines12122758.
9
Widespread Distribution of α-Synuclein Oligomers in -related Parkinson's Disease.α-突触核蛋白寡聚体在帕金森病中的广泛分布
bioRxiv. 2024 Dec 20:2024.12.18.629265. doi: 10.1101/2024.12.18.629265.
10
MJF-14 proximity ligation assay detects early non-inclusion alpha-synuclein pathology with enhanced specificity and sensitivity.MJF-14邻近连接分析可检测早期非包涵体α-突触核蛋白病变,具有更高的特异性和敏感性。
NPJ Parkinsons Dis. 2024 Nov 29;10(1):227. doi: 10.1038/s41531-024-00841-9.
J Neurol. 2022 Aug;269(8):4310-4321. doi: 10.1007/s00415-022-11067-1. Epub 2022 Mar 19.
4
Movement disorders research in 2021: cracking the paradigm.2021年运动障碍研究:突破范式
Lancet Neurol. 2022 Jan;21(1):10-11. doi: 10.1016/S1474-4422(21)00413-0.
5
Neuropathology and molecular diagnosis of Synucleinopathies.神经病理学和神经核蛋白病的分子诊断。
Mol Neurodegener. 2021 Dec 18;16(1):83. doi: 10.1186/s13024-021-00501-z.
6
Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease.路易体病中以边缘系统为主的与年龄相关的 TDP-43 脑病的特征。
Acta Neuropathol. 2022 Jan;143(1):15-31. doi: 10.1007/s00401-021-02383-3. Epub 2021 Dec 2.
7
Visualization of early oligomeric α-synuclein pathology and its impact on the dopaminergic system in the (Thy-1)-h[A30P]α-syn transgenic mouse model.在(Thy-1)-h[A30P]α-突触核蛋白转基因小鼠模型中观察早期寡聚化α-突触核蛋白病理学及其对多巴胺能系统的影响。
J Neurosci Res. 2021 Oct;99(10):2525-2539. doi: 10.1002/jnr.24927. Epub 2021 Jul 22.
8
Parkinson's disease.帕金森病。
Lancet. 2021 Jun 12;397(10291):2284-2303. doi: 10.1016/S0140-6736(21)00218-X. Epub 2021 Apr 10.
9
Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies.路易体痴呆患者基底核苍白球复合体 I 减少:路易体的作用。
Acta Neuropathol Commun. 2020 Jul 9;8(1):103. doi: 10.1186/s40478-020-00985-8.
10
Clinical and Imaging Markers of Prodromal Parkinson's Disease.前驱期帕金森病的临床和影像学标志物
Front Neurol. 2020 May 8;11:395. doi: 10.3389/fneur.2020.00395. eCollection 2020.